Compare RDHL & MTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RDHL | MTR |
|---|---|---|
| Founded | 2009 | 1979 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4M | 6.3M |
| IPO Year | 2012 | N/A |
| Metric | RDHL | MTR |
|---|---|---|
| Price | $0.86 | $3.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 151.4K | 8.7K |
| Earning Date | 04-27-2026 | 03-31-2026 |
| Dividend Yield | N/A | ★ 4.82% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $381.91 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $22.60 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.71 | $3.11 |
| 52 Week High | $3.31 | $5.98 |
| Indicator | RDHL | MTR |
|---|---|---|
| Relative Strength Index (RSI) | 51.41 | 22.12 |
| Support Level | $0.92 | N/A |
| Resistance Level | $1.07 | $4.94 |
| Average True Range (ATR) | 0.08 | 0.12 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 58.20 | 4.94 |
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.